Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Characterization of perioperative leukocytosis in patients undergoing robot-assisted radical prostatectomy: effects of Gleason score and race.

Patel T, Wambi C, Berg WT, Bergman A, Shapiro EY, Badani KK.

J Endourol. 2013 Dec;27(12):1463-7. doi: 10.1089/end.2013.0165. Epub 2013 Sep 28.

PMID:
24074199
2.

Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.

Zugor V, Witt JH, Heidenreich A, Porres D, Labanaris AP.

Anticancer Res. 2012 May;32(5):2091-5.

PMID:
22593494
3.
4.

Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: an Indian experience.

Singh P, Dogra PN, Gupta NP, Nayyar R, Seth A, Javali TD, Kumar R.

Indian J Cancer. 2011 Oct-Dec;48(4):483-7. doi: 10.4103/0019-509X.92275.

5.
6.

Biochemical outcomes after robot-assisted radical prostatectomy in patients with follow-up more than 5-years.

Kim KH, Lim SK, Shin TY, Chung BH, Hong SJ, Rha KH.

Asian J Androl. 2013 May;15(3):404-8. doi: 10.1038/aja.2013.5. Epub 2013 Mar 25.

7.

Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.

Abdollah F, Klett DE, Sood A, Sammon JD, Pucheril D, Dalela D, Diaz M, Peabody JO, Trinh QD, Menon M.

BJU Int. 2015 Nov;116(5):703-12. doi: 10.1111/bju.12998. Epub 2015 May 11.

PMID:
25413443
8.

Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Freedland SJ, Amling CL, Dorey F, Kane CJ, Presti JC Jr, Terris MK, Aronson WJ; Shared Equal Access Regional Cancer Hospital Database Study Group.

Urology. 2002 Oct;60(4):670-4.

PMID:
12385931
9.

A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.

Smith JA Jr, Chan RC, Chang SS, Herrell SD, Clark PE, Baumgartner R, Cookson MS.

J Urol. 2007 Dec;178(6):2385-9; discussion 2389-90. Epub 2007 Oct 22.

PMID:
17936849
10.

Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy?

Lam JS, Desai M, Mansukhani MM, Benson MC, Goluboff ET.

J Urol. 2003 Dec;170(6 Pt 1):2288-91.

PMID:
14634398
11.

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.

Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ.

Urology. 2000 Jul;56(1):87-91.

PMID:
10869631
12.

Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.

Ellis CL, Partin AW, Han M, Epstein JI.

J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056. Epub 2013 May 30.

PMID:
23727307
13.

The relationship between preoperative prostate-specific antigen and biopsy Gleason sum in men undergoing radical retropubic prostatectomy: a novel assessment of traditional predictors of outcome.

Pierorazio P, Desai M, McCann T, Benson M, McKiernan J.

BJU Int. 2009 Jan;103(1):38-42. doi: 10.1111/j.1464-410X.2008.07952.x. Epub 2008 Sep 3.

14.

Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.

Hashimoto T, Yoshioka K, Nagao G, Nakagami Y, Ohno Y, Horiguchi Y, Namiki K, Nakashima J, Tachibana M.

Int J Urol. 2015 Feb;22(2):188-93. doi: 10.1111/iju.12624. Epub 2014 Oct 22.

15.

Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.

Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D.

J Urol. 2001 Oct;166(4):1328-31; discussion 1331-2.

PMID:
11547067
16.

Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.

Freedland SJ, Terris MK, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Aronson WJ; Search Database Study Group.

J Urol. 2004 Jun;171(6 Pt 1):2215-20.

PMID:
15126788
17.

Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins.

Shapiro EY, Scarberry K, Patel T, Bergman A, Ahn JJ, Sahi N, RoyChoudhury A, Deutch I, McKiernan JM, Benson MC, Badani KK.

J Endourol. 2014 Feb;28(2):208-13. doi: 10.1089/end.2013.0393. Epub 2013 Nov 9.

PMID:
24044423
18.

Prostate cancer biochemical recurrence rates after robotic-assisted laparoscopic radical prostatectomy.

Ginzburg S, Nevers T, Staff I, Tortora J, Champagne A, Kesler SS, Laudone VP, Wagner JR.

JSLS. 2012 Jul-Sep;16(3):443-50. doi: 10.4293/108680812X13462882736538.

19.

Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.

Sooriakumaran P, Haendler L, Nyberg T, Gronberg H, Nilsson A, Carlsson S, Hosseini A, Adding C, Jonsson M, Ploumidis A, Egevad L, Steineck G, Wiklund P.

Eur Urol. 2012 Nov;62(5):768-74. doi: 10.1016/j.eururo.2012.05.024. Epub 2012 May 18.

PMID:
22633365
20.

Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer.

Pierorazio PM, Mullins JK, Eifler JB, Voth K, Hyams ES, Han M, Pavlovich CP, Bivalacqua TJ, Partin AW, Allaf ME, Schaeffer EM.

BJU Int. 2013 Oct;112(6):751-7. doi: 10.1111/j.1464-410X.2012.11757.x. Epub 2013 Jan 28.

Items per page

Supplemental Content

Write to the Help Desk